Investing Profile

Philippe Dro

InvestorVC
Partner at Adjuvant Capital
Photo of Philippe Dro, Partner at Adjuvant Capital
cb
$100K - $5.0M
$1.5M
2
$300M
CompanyStageDateRound SizeTotal Raised
Memo Therapeutics
Series CNov 2023$28M
Series BFeb 2022$25M
$75M
Co-investors: Hadrien Bouchez (Kurma Partners), Veronica Gambillara Fonck (Pureos Bioventures)